PROFUSA, INC. Investment Income, Interest
PROFUSA, INC. (PFSA) reported Investment Income, Interest of $15.16 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2025-08-14
- PROFUSA, INC. investment income, interest for the quarter ending 2025-06-30 was $15.16K, a 86.03% decline year-over-year.
- PROFUSA, INC. investment income, interest for the quarter ending 2025-03-31 was $79.92K, a 31.49% decline year-over-year.
- PROFUSA, INC. investment income, interest for the quarter ending 2024-12-31 was $91.48K, a 37.09% decline year-over-year.
- PROFUSA, INC. investment income, interest for the quarter ending 2024-09-30 was $108.75K, a 21.61% decline year-over-year.
- PROFUSA, INC. investment income, interest for fiscal 2024 was $425.42K, a 81.08% decline from fiscal 2023.
- PROFUSA, INC. investment income, interest for fiscal 2023 was $2.25M, a 12.82% decline from fiscal 2022.
- PROFUSA, INC. investment income, interest for fiscal 2022 was $2.58M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 8 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|---|
| 2025-06-30 | $15.16K 10-Q · filed 2025-08-14 | $95.08K 10-Q · filed 2025-08-14 | $186.57K derived: sum of 3 quarters · filed 2025-08-14 | $295.32K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2025-03-31 | $79.92K 10-Q · filed 2025-06-13 | $171.41K derived: sum of 2 quarters · filed 2025-06-13 | $280.16K derived: sum of 3 quarters · filed 2025-06-13 | $388.68K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-12-31 | $91.48K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $200.23K derived: sum of 2 quarters · filed 2025-03-31 | $308.75K derived: sum of 3 quarters · filed 2025-08-14 | $425.42K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $108.75K 10-Q · filed 2024-12-17 | $217.27K derived: sum of 2 quarters · filed 2025-08-14 | $333.93K 10-Q · filed 2024-12-17 | $479.36K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-06-30 | $108.52K 10-Q · filed 2025-08-14 | $225.18K 10-Q · filed 2025-08-14 | $370.61K derived: sum of 3 quarters · filed 2025-08-14 | $509.34K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $116.66K 10-Q · filed 2025-06-13 | $262.09K derived: sum of 2 quarters · filed 2025-06-13 | $400.82K derived: sum of 3 quarters · filed 2025-06-13 | $523.36K derived: sum of 4 quarters · filed 2025-06-13 | |
| 2023-12-31 | $145.43K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $284.15K derived: sum of 2 quarters · filed 2025-03-31 | $406.70K derived: sum of 3 quarters · filed 2025-03-31 | $2.25M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $138.72K 10-Q · filed 2024-12-17 | $261.27K derived: sum of 2 quarters · filed 2024-12-17 | $2.10M 10-Q · filed 2024-12-17 | $3.31M derived: sum of 4 quarters · filed 2024-12-17 | |
| 2023-06-30 | $122.55K 10-Q · filed 2024-11-15 | $1.96M 10-Q · filed 2024-11-15 | $3.18M derived: sum of 3 quarters · filed 2024-11-15 | $4.31M derived: sum of 4 quarters · filed 2024-11-15 | |
| 2023-03-31 | $1.85M 10-Q · filed 2024-10-09 | $3.05M derived: sum of 2 quarters · filed 2024-10-09 | $4.19M derived: sum of 3 quarters · filed 2024-10-09 | $4.35M derived: sum of 4 quarters · filed 2024-10-09 | |
| 2022-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $2.34M derived: sum of 2 quarters · filed 2024-02-26 | $2.51M derived: sum of 3 quarters · filed 2024-02-26 | $2.58M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $1.30M derived: sum of 2 quarters · filed 2023-11-20 | $1.37M 10-Q · filed 2023-11-20 | ||
| 2022-06-30 | $161.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $234.50K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $72.68K 10-Q · filed 2023-05-17 | ||||
| 2021-12-31 | $6.46K 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |